Related references
Note: Only part of the references are listed.Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway
Min-Jia Tan et al.
CHEMISTRY & BIOLOGY (2008)
Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet
Chun-Ching Shih et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase
Hsueh-Ling Cheng et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Cucurbitane-type triterpenoids from the stems of Momordica charantia
Chi-I Chang et al.
JOURNAL OF NATURAL PRODUCTS (2008)
Efficacy of Dietary Supplementation with Botanicals on Carbohydrate Metabolism in Humans
William Cefalu et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Bitter melon (Momordica charantia L.) inhibits adipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats
Hui-Ling Huang et al.
BRITISH JOURNAL OF NUTRITION (2008)
Extracts of Momordica charantia suppress postprandial hyperglycemia in rats
Takashi Uebanso et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2007)
Cucurbitane triterpenoids from Momordica charantia
Qing-Yan Li et al.
MAGNETIC RESONANCE IN CHEMISTRY (2007)
The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies
Antonio Miguel Limcaco Dans et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARα in bitter gourd (Momordica charantia L.)
Chia-Ying Chuang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Momordica charantia constituents and antidiabetic screening of the isolated major compounds
Liva Harinantenaina et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2006)
Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities
Sirintorn Yibchok-Anun et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus
Cheryl A. Lans
JOURNAL OF ETHNOBIOLOGY AND ETHNOMEDICINE (2006)
Effect of personal and cultural beliefs on medication adherence in the elderly
Lichun Rebecca Chia et al.
DRUGS & AGING (2006)
Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines
QX Chen et al.
BRITISH JOURNAL OF NUTRITION (2005)
Postprandial hyperglycemia and diabetes complications - Is it time to treat?
A Ceriello
DIABETES (2005)
Pharmacological actions and potential uses of Momordica charantia:: a review
JK Grover et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
Does bitter melon contain an activator of AMP-activated kinase?
MF McCarty
MEDICAL HYPOTHESES (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Antihyperglycemic effects of three extracts from Momordica charantia
J Virdi et al.
JOURNAL OF ETHNOPHARMACOLOGY (2003)
Systematic review of herbs and dietary supplements for glycemic control in diabetes
GY Yeh et al.
DIABETES CARE (2003)
Use of alternative medicines in diabetes mellitus
EA Ryan et al.
DIABETIC MEDICINE (2001)
Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets
AP Jayasooriya et al.
JOURNAL OF ETHNOPHARMACOLOGY (2000)
Share Paper
